STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

AERI AERIE PHARMACEUTICALS INCORPORATED StockScouter® Report

5

StockScouter® Score

AERIE PHARMACEUTICALS INCORPORATED, a small cap growth company in the healthcare sector, is expected to slightly outperform the market over the next six months with slightly higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Earnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. Positive
  • The most recent quarterly earnings report higher than analysts’ consensus forecast. Positive

 

Concerns

  • The enterprise value-to-sales ratio is higher than the average for comparably-sized companies in the StockScouter universe. Negative
  • One or more analysts has modestly decreased quarterly earnings estimates for AERI. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that small cap stocks will be neutral, growth stocks will be in favor, and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 80% done.
Progress: 80% done.
Low
High

Core Model Grades

A
C
D
B

Previous Ratings

4
3
4